|
Market Closed -
Toronto S.E.
15:56:52 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 25.61 CAD | -0.97% |
|
-2.18% | +13.87% |
| 09-02 | Altria sues FDA over tobacco product review system | RE |
| 09-02 | Altria sues to force US FDA to scrap system for reviewing tobacco products | RE |
Company Valuation: Philip Morris International Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 147,899 | 156,896 | 146,050 | 187,124 | 249,685 | 284,494 | - | - |
| Change | - | 6.08% | -6.91% | 28.12% | 33.43% | 13.94% | - | - |
| Enterprise Value (EV) 1 | 171,209 | 196,812 | 190,899 | 228,603 | 293,648 | 325,724 | 323,541 | 321,624 |
| Change | - | 14.95% | -3% | 19.75% | 28.45% | 10.92% | -0.67% | -0.59% |
| P/E | 16.3x | 17.4x | 18.7x | 26.6x | 22.1x | 24.6x | 21.2x | 18.9x |
| PBR | -14.6x | -17.5x | -13x | -15.9x | -25x | -42.1x | -60.6x | -89.2x |
| PEG | - | -50.72x | -1.4x | -2.67x | 0.4x | 11.13x | 1.3x | 1.6x |
| Capitalization / Revenue | 4.71x | 4.94x | 4.15x | 4.94x | 6.14x | 6.55x | 6.19x | 5.83x |
| EV / Revenue | 5.45x | 6.2x | 5.43x | 6.04x | 7.22x | 7.5x | 7.04x | 6.59x |
| EV / EBITDA | 11.8x | 14.3x | 13.5x | 14.7x | 16.9x | 16.7x | 15.6x | 14.7x |
| EV / EBIT | 12.7x | 15.2x | 14.3x | 15.6x | 17.9x | 18.2x | 16.8x | 15.6x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 4.9 | 5.04 | 5.2 | 5.4 | 5.64 | 5.99 | 6.391 | 6.756 |
| Rate of return | 5.16% | 4.98% | 5.53% | 4.49% | 3.52% | 3.28% | 3.5% | 3.7% |
| EPS 2 | 5.83 | 5.81 | 5.02 | 4.52 | 7.26 | 7.42 | 8.613 | 9.64 |
| Distribution rate | 84% | 86.7% | 104% | 119% | 77.7% | 80.7% | 74.2% | 70.1% |
| Net sales 1 | 31,405 | 31,762 | 35,174 | 37,878 | 40,648 | 43,427 | 45,976 | 48,836 |
| EBITDA 1 | 14,486 | 13,802 | 14,193 | 15,580 | 17,375 | 19,467 | 20,740 | 21,946 |
| EBIT 1 | 13,488 | 12,908 | 13,337 | 14,688 | 16,428 | 17,862 | 19,223 | 20,656 |
| Net income 1 | 9,109 | 9,048 | 7,813 | 7,057 | 11,348 | 11,586 | 13,423 | 14,982 |
| Net Debt 1 | 23,310 | 39,916 | 44,849 | 41,479 | 43,963 | 41,230 | 39,047 | 37,130 |
| Reference price 2 | 95.00 | 101.21 | 94.08 | 120.35 | 160.40 | 182.53 | 182.53 | 182.53 |
| Nbr of stocks (in thousands) | 1,556,828 | 1,550,202 | 1,552,406 | 1,554,833 | 1,556,639 | 1,558,613 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/6/25 | 2/6/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.6x | 7.5x | 16.73x | 3.28% | 284B | ||
| 12.38x | 4.54x | 9.57x | 6.08% | 120B | ||
| 9.36x | 2.77x | 6.35x | 6.71% | 25.56B | ||
| 36.46x | 2.73x | 23.18x | 1.78% | 7.77B | ||
| 58.77x | 2.82x | 20.68x | 0.43% | 1.51B | ||
| 14.34x | - | - | - | 1.14B | ||
| Average | 25.99x | 4.07x | 15.30x | 3.66% | 73.47B | |
| Weighted average by Cap. | 20.68x | 6.32x | 14.30x | 4.21% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PM Stock
- ZYNS Stock
- Valuation Philip Morris International Inc.
Select your edition
All financial news and data tailored to specific country editions
















